Huntington’s and ALS Nonprofits Partner with Teva to Discover New Therapeutic Targets
Three organizations fighting neurodegenerative diseases have teamed up to challenge researchers around the world to come up with new treatment approaches for central nervous system (CNS) disorders. The Huntington’s Disease Society of America (HDSA), the ALS Association, and Teva Pharmaceuticals have launched the crowdsourcing effort, called the …